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ABSTRACT Syntenin-1 is a cytosolic adaptor protein involved in several cellular processes 
requiring polarization. Human immunodeficiency virus type 1 (HIV-1) attachment to target 
CD4+ T-cells induces polarization of the viral receptor and coreceptor, CD4/CXCR4, and cel-
lular structures toward the virus contact area, and triggers local actin polymerization and phos-
phatidylinositol 4,5-bisphosphate (PIP2) production, which are needed for successful HIV in-
fection. We show that syntenin-1 is recruited to the plasma membrane during HIV-1 attachment 
and associates with CD4, the main HIV-1 receptor. Syntenin-1 overexpression inhibits HIV-1 
production and HIV-mediated cell fusion, while syntenin depletion specifically increases HIV-1 
entry. Down-regulation of syntenin-1 expression reduces F-actin polymerization in response 
to HIV-1. Moreover, HIV-induced PIP2 accumulation is increased in syntenin-1–depleted cells. 
Once the virus has entered the target cell, syntenin-1 polarization toward the viral nucleo-
capsid is lost, suggesting a spatiotemporal regulatory role of syntenin-1 in actin remodeling, 
PIP2 production, and the dynamics of HIV-1 entry.
INTRODUCTION
The adaptor protein syntenin-1 was originally described in relation 
to its association with the syndecan receptor and its recycling 
(Grootjans et al., 1997; Zimmermann et al., 2005). It was also termed 
melanoma differentiation-associated gene-9 (mda-9) for its up-reg-
ulated expression in several types of tumors, which correlates with 
high invasiveness (Sarkar et al., 2004, 2008). Structurally, syntenin-1 
contains a regulatory N-terminal region and two tandem postsyn-
aptic density protein, Drosophila disk large, and zonula occludens-1 
(PDZ) domains. The N-terminal region is composed of two Tyr-
based domains: one ITIM and one ITAM domain, the ITIM domain 
being important for CXCR4-mediated T-cell migration (Sala-Valdes 
et al., 2012). PDZ domains are involved in the formation of macro-
molecular complexes that often link transmembrane proteins to the 
actin cytoskeleton, mediating their clustering and polarized subcel-
lular distribution (Fanning and Anderson, 1999; Brone and Egger-
mont, 2005; Hirbec et al., 2005; Ludford-Menting et al., 2005). PDZ 
domains interact with short amino acid sequences at the C-terminal 
end of plasma membrane proteins. Three consensus sequences 
bind PDZ domains: class I ([S/T]-X-Φ), class II (Φ-X-Φ), and class III 
([D/E]-X-Φ), where X is any amino acid and Φ is a hydrophobic resi-
due (Chimura et al., 2011). Through its PDZ domains, syntenin-1 
binds to transmembrane proteins, such as CD6 (Gimferrer et al., 
2005) and the tetraspanin CD63 (Latysheva et al., 2006); signaling 
proteins, such as the tyrosine kinase Src (Boukerche et al., 2008); 
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of syntenin-1 recruitment, we assessed CD45 distribution and ob-
served that it did not accumulate at virus-induced capping areas 
(Figure 1, B and E). In addition, to assess that syntenin-1 recruitment 
was Env-mediated, target CEM-T4 cells were incubated with a Jur-
kat clone expressing the T-tropic HIV-1 envelope HxB (Env+ HxBc2 
cells). Syntenin-1 was found at the Env-driven cell contacts, together 
with CD4 (Figure 1, C and E). We also cocultured target CEM-T4 
cells with T-cells directly infected with HIV–green fluorescent protein 
(GFP) virus (MT4-HIV-GFP). In these cocultures, syntenin-1 accumu-
lated at cell–cell contacts, areas in which viral synapses are estab-
lished (Figure 1, D and E), but not at unspecific Env-independent 
cell–cell contacts (Figure1E, right-hand white bar; exemplified in 
Supplemental Figure S1). Quantification confirmed significant ac-
cumulation of syntenin-1 at contacts with HIV-1 viral particles and 
infected cells, in comparison with CD45 (Figure 1E).
Syntenin-1 associates with the cytoplasmic tail of CD4
PDZ domains usually bind to specific consensus sequences at the 
C-terminal ends of transmembrane proteins (Chimura et al., 2011). 
To determine whether syntenin-1 forms part of the CD4/CXCR4 
complex at the capping areas, we first searched the CD4 and CXCR4 
cytoplasmic domain sequences for potential PDZ-binding motifs. A 
class I PDZ-binding consensus sequence (Ser-Pro-Ile) was detected 
at the C-terminal end of CD4, suggesting potential direct interac-
tion with syntenin-1 via its PDZ domains. To test this, we immobi-
lized glutathione S-transferase (GST)-fused hemagglutinin (HA)- or 
Myc-tagged syntenin-1 on Sepharose beads, and incubated them 
with human primary lymphoblast lysates. GST-syntenin-HA and GST-
syntenin-Myc, but not GST alone, precipitated CD4 (Figure 2A). 
Confirming this interaction, anti-CD4 antibody immunoprecipitated 
endogenous syntenin-1 from CEM T-cell lysates; syntenin-1 was de-
tected with anti–syntenin-1 antibody as a double band of around 
32 kDa (Figure 2B). To demonstrate the occurrence of CD4–syn-
tenin-1 association in the context of HIV-1 infection, we performed 
reverse immunoprecipitation assays with Jurkat T-cells previously 
incubated with free viral particles. Immunoprecipitation of syn-
tenin-1, followed by immunodetection of CD4, detected constitu-
tive CD4–syntenin-1 interaction that was maintained during HIV-1 
contact (Figure 2C). Together, these data suggest that syntenin-1 
interacts with CD4 before and during HIV-1 infection.
Syntenin-1 overexpression inhibits HIV-1–induced cell 
fusion and viral production
To assess the specific role of syntenin-1 during HIV-1 infection, target 
T-cells were transfected with GFP-tagged, wild-type syntenin-1 (syn-
tenin-GFP) or a mutated protein, syntenin-Y1-GFP (Synt-Y1-GFP), 
which carries a Y4>F point mutation in the ITIM motif of the regula-
tory N-terminal region. Phosphorylation of endogenous syntenin-1 
at this tyrosine residue has been shown to be essential for CXCR4-
induced chemotaxis (Sala-Valdes et al., 2012). Syntenin-GFP and 
Synt-Y1-GFP showed a similar distribution to endogenous syn-
tenin-1, being enriched at Env-driven cell–cell contacts (Figure 3A) 
and HIV-induced capping areas (Figure 3B and data not shown). Tar-
get J77 cells overexpressing these GFP-tagged proteins were in-
fected with free HIV-1 particles, and viral production was measured 
3 d later by p24 enzyme-linked immunosorbent assay (ELISA). Cells 
overexpressing syntenin-GFP produced lower viral titers than control 
cells (transfected with GFP alone). In contrast, overexpression of the 
mutated syntenin-1 had no effect on HIV-1 production (Figure 3C).
To investigate the potential effect of syntenin-1 plasma mem-
brane recruitment on HIV-1–induced cell fusion, we measured 
Env-mediated cell fusion by flow cytometry. Env+ HxBc2 cells 
and the actin-linker protein merlin (Jannatipour et al., 2001). Re-
cruitment of syntenin-1 to the plasma membrane is also regulated 
through its PDZ-mediated interaction with the lipid second mes-
senger phosphatidylinositol 4,5-bisphosphate (PIP2; Zimmermann, 
2006).
Syntenin-1 has a cytosolic distribution, being enriched in vesicles 
and F-actin structures (Zimmermann et al., 2001). It is implicated in 
several actin-polarized processes, such as cell migration, immune 
synapse formation, intracellular trafficking, cell-surface targeting, 
axonal outgrowth, and synaptic transmission (Gimferrer et al., 2005; 
Hirbec et al., 2005; Zimmermann et al., 2005; Beekman and Coffer, 
2008; Sarkar et al., 2008). We recently reported the involvement of 
syntenin-1 in CXCR4-mediated T-chemotaxis and T-APC antigen 
presentation, in which it regulates Rac-triggered actin polymeriza-
tion (Sala-Valdes et al., 2012).
CD4/CXCR4-derived signaling and Rac-induced actin remodel-
ing are also important for human immunodeficiency virus type 1 
(HIV-1) infection (Pontow et al., 2004; Carter et al., 2009). Soon after 
HIV-1 contact with CD4+ T-cells, the viral envelope glycoprotein 
complex gp120/gp41 (Env) engages with CD4 and CXCR4, inducing 
several signaling pathways that trigger receptor clustering (Jimenez-
Baranda et al., 2007; Barrero-Villar et al., 2009) in a structure called 
“cap” (Dianzani et al., 1995; Nguyen et al., 2005), local actin polym-
erization (Iyengar et al., 1998; Jolly et al., 2004), T-cell activation 
(Popik et al., 1998; Hiscott et al., 2001), and HIV-1 replication (Popik 
and Pitha, 2000; Mettling et al., 2008). These rearrangements en-
hance viral entry (Wu and Yoder, 2009; Juno and Fowke, 2010) by 
supplying an optimal density of CD4/CXCR4 complexes through 
actin-mediated surface reorganization (Iyengar et al., 1998; Doms, 
2000; Jolly et al., 2004). Thus the actin-binding proteins moesin and 
filamin-A accumulate at the F-actin–enriched capping areas and in-
fluence CD4/CXCR4 clustering (Jimenez-Baranda et al., 2007; 
Barrero-Villar et al., 2009). Moreover, we previously showed that 
HIV-1 gp120, through its interaction with CD4, induces local produc-
tion of PIP2 by activating PI4P5K-Iα (Barrero-Villar et al., 2008).
After viral attachment to the plasma membrane, the local F-actin 
accumulation can constitute a physical barrier for entry of the viral 
nucleocapsid (Vasiliver-Shamis et al., 2009). In this regard, CXCR4-
gp120 interaction was recently shown to activate cofilin, which pro-
motes actin clearance, facilitating nucleocapsid entry into the cyto-
plasm (Yoder et al., 2008).
In this study, we assessed the possible role of syntenin-1 as a 
mediator of CD4/CXCR4 clustering and actin remodeling during 
HIV-1 infection. Our data indicate that syntenin-1 associates with 
CD4 and negatively regulates HIV-1 infection by affecting the 
dynamic reorganization of actin cytoskeleton and PIP2 production 
triggered upon HIV-1 contact, specifically at the viral entry step.
RESULTS
Syntenin-1 is recruited to the plasma membrane 
by HIV-1 Env
PDZ proteins commonly determine the polarization of cellular events 
(Fanning and Anderson, 1999; Brone and Eggermont, 2005; 
Ludford-Menting et al., 2005). Because HIV-1 contact with target 
cells triggers the polarization of cellular components (Dianzani et al., 
1995; Nguyen et al., 2005), we investigated whether the PDZ pro-
tein syntenin-1 was recruited upon HIV-1 contact with target CD4+ 
T-cells (CEM-T4). In the absence of HIV-1 virus, syntenin-1 displayed 
a diffuse cytosolic pattern with low clustering at the plasma mem-
brane (Figure 1A). In contrast, after incubation of T-cells with free 
HIV-1 particles, syntenin-1 was clearly recruited toward the CD4/
CXCR4 capping area (Figure 1, A and E). To confirm the specificity 
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were labeled with red intracellular tracker 
(CMTMR; 5-(and-6)(((4chloromethyl)benzoyl)-
amino) tetramethylrhodamine) and cocul-
tured with target T-cells transfected with 
each GFP-tagged syntenin-1 construct. Env-
driven cell fusion leads to syncytia forma-
tion, detected as double-fluorescence 
positive events of higher size and complex-
ity. As a control of specificity, syncytia for-
mation was blocked with the HIV-1 fusion 
inhibitor T-20 (Figure 3D). Quantification of 
these events showed that overexpression 
of wild-type syntenin-1 reduced Env-medi-
ated cell fusion, whereas the Y4>F mutant 
had no significant effect (Figure 3D). These 
data suggest that syntenin-1 negatively 
regulates HIV-1–mediated membrane fu-
sion through a mechanism requiring phos-
phorylation of tyrosine 4 in the ITIM motif. 
To assess whether the Y4>F point mutant 
was able to interact with CD4, cells were 
transfected with syntenin-GFP or Synt-
Y1-GFP, immunoprecipitated with an anti-
GFP, and blotted for CD4. As shown in 
Figure 3E, Synt-Y1-GFP also associated 
with CD4.
Knockdown of syntenin-1 expression 
increases HIV-1 cell fusion and viral 
entry
To further study syntenin-1 function during 
HIV-1 infection, we knocked down endoge-
nous syntenin-1 expression using small inter-
fering RNA (siRNA). Control cells were trans-
fected with an siRNA sequence that does 
not hybridize with any eukaryotic mRNA. 
Syntenin-1 down-regulation was assessed 
for each experiment (Figure 4A and data not 
shown). Membrane expression levels of CD4 
and CXCR4 were also routinely assessed to 
confirm that they were not affected by syn-
tenin depletion (Figure 4B). To assess Env-
driven cell fusion, silenced T-cells loaded 
with green cell tracker were cocultured with 
FIGURE 1: Syntenin-1 is recruited by HIV-1 envelope glycoproteins. (A) CEM-T4 cells incubated 
with or without HIV-1 particles for 30 min were fixed and immunostained for syntenin-1 and CD4 
(HP2/6). Summative projections of confocal stack images are shown. Scale bars: 5 μm. Surface 
plots show fluorescence distribution and intensity for corresponding images. (B) CEM-T4 cells 
incubated with HIV-1 particles for 30 min were fixed and immunostained for CD4 (CD4v4-FITC) 
and CD45 (D3/9). Summative projections of confocal stack images are shown. Scale bar: 5 μm. 
Surface plots show fluorescence distribution and intensity for corresponding images. 
(C) Immunofluorescence microscopy images of target CEMT4 cells incubated for 2 h with Env+ 
HxBc2 cells (CMAC stained, blue) and stained for syntenin-1 and CD4 (HP2/6). Scale bars: 5 μm. 
(D) Target J77 cells were incubated for 2 h 
with HIV-1–infected T-cells (MT4-HIV-GFP) 
and immunostained for syntenin-1 and CD4 
(HP2/6). Projections of confocal stack images 
are shown. Scale bar: 5 μm. (E) Quantification 
of syntenin-1 accumulation at HIV-1-induced 
capping areas (HIV-wt), contacts between 
target cells and HIV-infected cells (MT4-J77), 
or contacts between target cells and Env+ 
cells (HxB-J77). The control (white bars) for 
HIV wild-type and MT4-J77 represent the 
recruitment of CD45. The control (white bar) 
for HxB-J77 corresponds to the recruitment 
of syntenin at Env-independent cell–cell 
contacts (between two target J77 cells). The 
chart represents the mean ± SD of three 
independent experiments; more than 100 
conjugates were counted in each condition.
2256 | M. Gordón-Alonso et al. Molecular Biology of the Cell
Higher luciferase levels were found in X4-Luc–infected syntenin-1–si-
lenced cells, confirming that syntenin-1 knockdown specifically in-
creases viral entry (Figure 5B). VSV infection was similar in silenced 
and control cells, demonstrating that the effect observed is HIV-1 
Env-dependent (Figure S2). These results indicate that syntenin-1 
negatively regulates HIV-1 entry without affecting viral attachment.
To study the behavior of syntenin-1 during viral attachment and 
entry in more detail, we incubated Gag-GFP fluorescent virus-like 
particles (VLPs) with T-cells at 4°C or 37°C. At 4°C, VLPs attached 
preferentially to one pole of the target cell (Figure S3; see Supple-
mental Movie S1 for three-dimensional reconstruction), which sug-
gests that the capping area behaves as the main site for viral entry, 
as has been proposed (Doms, 2000; Nguyen et al., 2005). At 37°C, 
VLPs could be observed inside target cells, usually accumulated at 
one pole of the cytoplasm (Figure S3; see Movie S2 for three-dimen-
sional reconstruction).
We next examined the localization of endogenous syntenin-1 by 
confocal immunostaining of T-cells exposed to VLPs. To avoid false 
positives due to fortuitous superposition, we only analyzed planes 
in which VLPs were detected (usually one to two planes distanced 
by 0.25 μm). Syntenin-1 was enriched at VLP attachment sites in 
cells kept at 4°C (Figure 5, C and F), whereas barely any syntenin-1 
localized at the internalized VLPs in cells incubated at 37°C (Figure 
5, D and F). However, syntenin-1 did accumulate near VLPs posi-
tioned at cell–cell contacts at 37°C (Figure 5, E and F). Quantifica-
tion of syntenin-1 accumulation at VLPs at each temperature and 
location confirmed that association of syntenin-1 with VLPs occurs 
only on the plasma membrane, and not once the particles are 
already internalized (Figure 5F).
Thus syntenin-1 is recruited to the plasma membrane by HIV-1 
Env during the attachment and entry steps but affects only the 
effectiveness of viral entry, and it is released from the viral complex 
once the nucleocapsid has entered the cytoplasm.
Syntenin-1 regulates actin polymerization and PIP2 
accumulation upon HIV-1 contact
Syntenin-1 was recently found to regulate F-actin polymerization via 
Rac GTPase in T-cells during CXCR4-induced chemotaxis and su-
perantigen presentation (Sala-Valdes et al., 2012). This syntenin-1–
mediated activation of Rac depends on phosphorylation of tyrosine 4 
(Sala-Valdes et al., 2012). Moreover, Rac-mediated actin reorganiza-
tion is known to be essential for HIV-1 entry (Iyengar et al., 1998; 
Pontow et al., 2004; Harmon et al., 2010). To analyze the relation 
between syntenin-1 and F-actin during HIV-1 infection, we incubated 
target cells with VLPs, stained them for syntenin-1 and F-actin, and 
analyzed them with confocal microscopy. Syntenin-1 clusters at the 
plasma membrane corresponded with the VLP contact area and par-
tially overlapped with F-actin accumulation (Figure 6A; see Figure S4 
for F-actin staining in noninfected target cells). Given that HIV-1 at-
tachment to CD4 and CXCR4 triggers local actin polymerization (Jolly 
et al., 2004), we analyzed this process in syntenin-1–depleted cells. A 
similar percentage of VLPs colocalized with F-actin in control and 
syntenin-1–depleted cells (Figure 6A). However, when actin polymer-
ization after HIV-1 contact was monitored at different time points, 
control cells showed a marked increase in F-actin content 30 min after 
HIV-1 contact, whereas F-actin polymerization was markedly lower in 
syntenin-1–depleted cells (Figure 6B). These data indicate that syn-
tenin-1 is required for HIV-1–triggered F-actin polymerization at early 
stages, when most virus particles are observed at the plasma mem-
brane. Moreover, F-actin accumulation at cell–cell contacts between 
target and infected MT4 cells was reduced in cells knocked down for 
syntenin in comparison with control cells (Figure 6C).
Env+ HxBc2 cells labeled with red cell tracker. Syntenin-1–depleted 
cells exhibited enhanced cell fusion with Env+ cells compared with 
control cells (Figure 4C). Furthermore, syntenin-1–depleted cells 
produced higher viral titers than control cells upon infection with free 
HIV-1 virions (Figure 4D). Importantly, this effect could be rescued by 
syntenin-GFP overexpression in silenced T-cells (Figure 4E). Taken 
together, these results confirm the inhibitory role of syntenin-1 in 
HIV-1 infection.
Syntenin-1 restricts HIV-1 entry
Syntenin-1 recruitment at the plasma membrane suggested its in-
volvement during HIV-1 attachment or entry steps. To distinguish 
between these possibilities, we incubated syntenin-1–depleted cells 
with HIV-1 particles for 2 h at 4°C, a temperature that does not allow 
Env-induced membrane fusion, thus arresting the virus at the attach-
ment step, or at 37°C, a permissive temperature for membrane fu-
sion and consequently for viral entry. For both conditions a low infec-
tion rate was used to avoid superinfection and cooperative virion 
entry. The amount of p24 in the lysates was measured by ELISA 
(Figure 5A) and Western blot (data not shown); HIV-1 attachment was 
estimated from the p24 level at 4°C, and HIV entry was estimated 
from the difference between the levels at 37 and 4°C. Syntenin-1 si-
lencing enhanced virus entry without affecting viral attachment (4°C), 
suggesting that syntenin-1 specifically impairs HIV entry (Figure 5A). 
To confirm these observations, we infected target cells with a one-
cycle luciferase virus displaying a T-tropic envelope (X4-Luc), or the 
vesicular stomatitis virus (VSV) envelope (VSV-Luc) as a control. 
FIGURE 2: Syntenin-1 interacts with CD4 during HIV infection of 
T-cells. (A) T-lymphoblast cell lysates (Lys) were pulled down with GST, 
GST-syntenin-Myc, or GST-syntenin-HA, and blotted with anti-CD4 
mAb MEM241. (B) CEM T-cell lysates were immunoprecipitated with 
anti-CD4 mAb OKT4 (IP-OKT4) and anti-syntenin pAb (IP-Synt), and 
then blotted for syntenin-1 (pAb) and CD4 (mAb MEM241). Total 
lysates (Lys) and Sepharose beads incubated with lysates (Seph+Lys) 
are shown. (C) Jurkat J77 T-cells incubated with or without HIV-1 
particles were lysed, immunoprecipitated with anti–syntenin-1 pAb, 
and blotted with anti-CD4 mAb MEM241.
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local production of PIP2. Control or syntenin-1–depleted cells were 
incubated with MT4-HIV-GFP cells for 2 h and then fixed and stained 
for PIP2 with anti-PIP2 mAb. Syntenin-1–depleted T-cells showed in-
creased accumulation of PIP2 at contacts with HIV-1–infected T-cells 
(Figure 6D). To confirm that this effect was related to HIV-1 Env-
dependent contacts, we quantified PIP2 accumulation in target cells 
Interaction of the HIV-1 envelope with CD4 triggers PIP2 produc-
tion (Barrero-Villar et al., 2008), and this lipid has been found to regu-
late not only syntenin-1 recruitment to the plasma membrane 
(Zimmermann et al., 2005) but also many other actin-related proteins 
(Saarikangas et al., 2010). We therefore assessed whether syntenin-
1–dependent actin polymerization upon HIV-1 contact was related to 
FIGURE 3: Overexpression of wild-type syntenin-1, but not a phosphorylation-defective mutant, in target T-cells impairs 
HIV-1 infection. (A) CEM-T4 cells overexpressing syntenin-GFP or Synt-Y1-GFP (containing the Y4>F point mutation) 
were incubated with Env+ HxBc2 cells (tracked with CMAC, blue) for 2 h, fixed, and stained for CD4 (HP2/6 mAb). 
Summative projections of confocal stack images are shown. Scale bars: 5 μm. (B) CEM-T4 cells overexpressing wild-type 
syntenin-1 (syntenin-GFP) were incubated for 30 min with or without HIV-1 particles, fixed, and stained for CD4 (HP2/6 
mAb). Projections of confocal stack images are shown. Scale bars: 5 μm. (C) HIV-1 infection is inhibited by syntenin-GFP 
but not by Synt-Y1-GFP. Infection was measured as viral production, quantified as p24 viral protein content in 
supernatants (ELISA). Data are the fold induction relative to control cells transfected with GFP alone (mean ± SD of four 
experiments performed in triplicate; p = 0.0058). (D) Cell fusion triggered by HIV-1 envelope is reduced in cells 
overexpressing syntenin-GFP. As a control, syncytia formation was blocked by incubation with the fusion inhibitor 
T20 (10 nM). Data are the fold induction relative to GFP-transfected cells (mean ± SD of four experiments performed in 
duplicate; p = 0.031). (E) Cells were transfected with GFP, syntenin-GFP, or Synt-Y1-GFP; immunoprecipitated with pAb 
anti-GFP; and blotted for CD4 (MEM241) and GFP (mAb).
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To assess whether syntenin-1 depletion 
increases PIP2 accumulation in virus–cell con-
tacts, we transfected control and syntenin-
1–depleted cells with PLCδ-PH-GFP (pleck-
strin homology domain of PLC-delta tagged 
to GFP), a biosensor that binds to PIP2-en-
riched membranes (Varnai and Balla, 1998), 
and incubated them with Cherry-fluorescent 
VLPs expressing HxB (T-tropic) envelope. 
Patches of PLCδ-PH-GFP were frequently 
observed on the target cell surface at sites of 
VLP attachment (a representative image is 
shown in Figure 6F). The frequency of these 
events was higher in syntenin-1–depleted 
cells (Figure 6F). Taken together, these data 
indicate that syntenin-1 depletion increases 
PIP2 accumulation at Env-driven contacts 
both of cell–cell and of virus–cell interac-
tions, correlating with lower F-actin polymer-
ization and higher viral entry.
DISCUSSION
In this study we show that syntenin-1 is re-
cruited toward HIV-1 Env-driven virus–cell 
and cell–cell contacts, associates with CD4, 
limits HIV-1–induced cell fusion and viral en-
try, and modulates Env-triggered F-actin re-
modeling and PIP2 production.
HIV-1 binding to CD4/CXCR4 complexes 
at the T-cell surface activates several signal-
ing pathways and triggers local actin poly-
merization (Iyengar et al., 1998; Jolly et al., 
2004), which is essential for receptor clus-
tering at the plasma membrane (Iyengar 
et al., 1998; Jolly et al., 2004, 2007; Pontow 
et al., 2004). The actin-binding proteins fil-
amin-A and ERMs are known to favor CD4/
CXCR4 clustering during HIV-1 attachment 
(Jimenez-Baranda et al., 2007; Barrero-Villar 
et al., 2009). Filamin-A is needed for a tran-
sient cofilin inactivation through a RhoA-
ROCK–dependent mechanism that stabi-
lizes F-actin during HIV-1 attachment 
(Jimenez-Baranda et al., 2007). ERMs are 
activated by phosphorylation upon HIV-1 
contact and are essential for F-actin polar-
ization and CD4/CXCR4 clustering (Barrero-
Villar et al., 2009). In contrast with these 
actin-binding proteins, syntenin-1 does not 
affect HIV-1 attachment and therefore does 
not seem to be involved in HIV-1–induced 
CD4/CXCR4 clustering.
Instead, syntenin-1 binding to CD4 might 
block Lck activation or other CD4-derived 
pathways, thus hampering HIV-1 entry. How-
ever, since syntenin-1 depletion reduces ac-
tin polymerization soon after HIV-1 contact, the most plausible expla-
nation for its inhibitory effect is that it induces an actin accumulation 
at the viral attachment site that hinders viral nucleocapsid entry at the 
cell surface. Localized actin clearance during HIV-1 entry has been 
proposed as a mechanism for overcoming this physical restriction 
(Yoder et al., 2008; Liu et al., 2009; Vasiliver-Shamis et al., 2009), and 
cocultured with Env+ HxBc2 cells (heterotypic, Env-driven contacts) 
or cultured alone (homotypic, Env-independent contacts between 
target cells; Figure 6E and see Figure S5 for an example image). 
Syntenin-1 knockdown specifically increased PIP2 accumulation at 
Env-driven contacts, while having no effect on Env-independent con-
tacts (Figure 6E).
FIGURE 4: Knockdown of syntenin-1 expression increases HIV-1 entry and syncytia formation. 
(A) Representative Western blot showing silencing of endogenous syntenin-1 expression using 
oligonucleotide J-008270-08 in T-cells 48 h after siRNA transfection. Numbers below the blot 
show band intensity ratios between cells transfected with control siRNA and syntenin-1 siRNA, 
expressed relative to tubulin. (B) Bar chart showing surface expression levels (mean fluorescence 
intensity) of CD4 and CXCR4 in control and syntenin-depleted cells measured by flow cytometry. 
(C) Syntenin-1 silencing in target T-cells favors syncytia formation induced by Env+ HxBc2 cells. 
Syncytia formation was quantified by flow cytometry detection of double-positive fluorescent 
cells and is presented as the fold induction relative to cells transfected with control siRNA (mean 
± SD of four independent experiments performed in duplicate; p = 0.017). As a control, syncytia 
formation was blocked by incubation with the fusion inhibitor T20 (10 nM). (D) Effect of 
syntenin-1 silencing on HIV-1 infection. Infection was measured as viral production (p24 viral 
protein content in supernatants [ELISA]) and depicted as the mean fold induction relative to cells 
transfected with control siRNA (mean ± SD of four experiments performed in triplicate; 
p = 0.025). (E) Syntenin-1-GFP overexpression on cells knocked down for the endogenous 
syntenin-1 rescues the level of HIV-1 infection. Infection was measured as p24 viral protein 
content in supernatants (ELISA) and quantified as the mean fold induction relative to cells 
transfected with control siRNA + GFP (mean ± SD of two experiments performed in triplicate).
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cofilin activation and its actin-severing func-
tion have been linked to enhanced HIV entry 
(Yoder et al., 2008). Thus a reduced F-actin 
structure after HIV-1 attachment renders cells 
more susceptible to subsequent HIV-1 nucle-
ocapsid entry, as occurs in syntenin-depleted 
cells.
Higher HIV-1–mediated cell fusion and 
viral entry in syntenin-1–depleted target 
T-cells also correlates with increased PIP2 
production at Env-mediated cell–cell con-
tacts. PIP2 is an important second messen-
ger that targets proteins to the plasma 
membrane and regulates many actin-related 
proteins, such as ERMs, filamin, cofilin, and 
α-actinin (Saarikangas et al., 2010). Genera-
tion of PIP2 triggers local actin cytoskeleton 
changes by activating ERMs (Nakamura 
et al., 1999), recruiting cofilin (van Rheenen 
et al., 2009), and inhibiting α-actinin bun-
dling activity (Corgan et al., 2004). Overall, 
these pathways might favor HIV-1 mem-
brane fusion by facilitating receptor cluster-
ing and subsequent actin clearance (Liu 
et al., 2009). Remarkably, although PIP2-
associated cofilin is inactive in tumor cells, 
cofilin activation in leukocytes is mainly 
regulated by dephosphorylation (van 
Rheenen et al., 2009), which is in fact in-
duced upon HIV-1 contact through CXCR4-
derived signaling (Yoder et al., 2008). Thus 
PIP2 might switch the association of mem-
brane receptors and their cytosolic partners 
(Zimmermann et al., 2005; Saarikangas 
et al., 2010), modulating the links between 
transmembrane proteins and the subcorti-
cal actin cytoskeleton, and subsequently 
altering the association of proteins belong-
ing to the same signaling pathway. In this 
FIGURE 5: Syntenin-1 specifically inhibits viral entry and coclusters with fluorescent VLPs at the 
plasma membrane. (A) Effect of syntenin-1 silencing on HIV-1 attachment (4°C) and entry 
(37–4°C) into target T-cells. Data present the fold induction relative to control cells (mean ± SD 
of three experiments performed in triplicate; p = 0.016). (B) HIV-1 entry in syntenin-silenced cells 
measured by infection with one-cycle viral particles carrying a luciferase reporter gene. Data 
present the fold induction of luciferase-HIV-1-envelope virus relative to control cells and 
normalized to values obtained with luciferase-VSV-envelope virus (mean ± SD from four 
independent experiments performed in triplicate; p = 0.038). (C) Confocal images showing the 
recruitment of endogenous syntenin-1 toward attached VLPs (Gag-GFP) at 4°C. Images are 
projections of the planes in which each individual VLP is observed. Scale bar: 5 μm. Syntenin-1 
staining is shown in pseudocolor intensity-coding format next to the confocal image. The small 
panels are zoomed views of VLP contacts from pseudocolor syntenin-1 and merged 
immunostaining images (×3). Note that the 
maximum intensity of syntenin-1 staining 
(white on the pseudocolor scale images) 
overlaps the VLP attachment site. 
(D) Confocal images showing endogenous 
syntenin-1 distribution in target T-cells with 
internalized VLPs (37°C). Two VLPs are 
shown: one with low syntenin-1 clustering 
and another with no clustering. Scale bar: 
5 μm. Small panels as in (C). (E) Confocal 
images showing endogenous syntenin-1 
distribution in target T-cells forming cell–cell 
contacts with cells infected with VLPs. 
Contacts are productive sites for viral transfer 
and also recruit syntenin-1. Scale bar: 5 μm. 
Small panels as in (C). (F) Quantification of 
the number of VLPs that cluster syntenin-1 at 
the surface of target T-cells (4°C, attached 
particles), in the cytoplasm (37°C, intracellular 
particles) or at cell–cell contacts (37°C). 
Results are from at least three independent 
experiments and more than 100 VLPs were 
quantified for each condition.
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FIGURE 6: Actin polymerization is reduced in syntenin-1–depleted T-cells. (A) J77 T-cells were incubated with fluorescent 
VLPs (Gag-GFP) for 30 min, fixed, and stained for syntenin-1 and F-actin. The panels show projections of selected 
confocal planes in which a VLP was observed, with corresponding pseudocolor images below. Scale bar: 5 μm. The 
zoomed image shows the particle site (boxed region in merged image) together with orthogonal sections. Quantification 
of VLPs that colocalized with F-actin in cells silenced or not for syntenin-1 is shown at the right. No significant difference 
was observed. (B) Time profile of F-actin content upon contact with HIV-1 particles, measured by flow cytometry in 
control or syntenin-depleted cells. Data are means ± SD of four independent experiments. (C) F-actin accumulation at 
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Research and Reference Reagent Program and were cultured ac-
cording to NIH instructions. The chronically infected MT4-NL4.3-GFP 
cell line (MT4-HIV-GFP) was generated by Nuria Izquierdo-Useros at 
the laboratory of Martinez-Picado (IrsiCaixa, Barcelona, Spain).
The biotinylated monoclonal anti-CXCR4 antibody was from BD 
PharMingen. Mouse monoclonal anti–α-tubulin was from Sigma-
Aldrich (Saint Louis, MO). Anti-CD4 monoclonal antibodies used 
were HP2/6 (Gordon-Alonso et al., 2006), OKT4 (eBioscience), RPA-
T4 (eBioscience, San Diego, CA), CD4v4-FITC (BD PharMingen, 
Franklin Lakes, NJ), and MEM 241 (Abcam, Cambridge, UK). Rabbit 
polyclonal anti–syntenin-1 was from Synaptic Systems (Göttingen, 
Germany). The anti-CD45 mAb was clone D3/9, previously de-
scribed (Gordon-Alonso et al., 2006). Anti-PIP2 mAb was from Santa 
Cruz Biotechnology (clone 2C11; Santa Cruz, CA). Anti-GFP anti-
bodies (pAb for IP and mAb for WB) were from Living colors (Clon-
tech, Mountain View, CA). HRP-conjugated secondary antibodies 
were from Pierce (Rockford, IL).
The intracellular fluorescent trackers CMAC, Calcein-AM, and 
CM-TMR and all fluorochrome-conjugated secondary antibodies 
and phalloidins were from Molecular Probes (Camarillo, CA). The 
HIV-1-specific fusion inhibitor T20 (Enfuvirtide) was from Roche 
Diagnostics.
Cell transfection, DNA and siRNA
J77 cells (2 × 107) were electroporated in cold Optimem (Life Technol-
ogies-BRL, Camarillo, CA) with DNA (20 mg) or with siRNA (1.25 mM) 
using a Bio-Rad GenePulser II electroporator (240 V; 950°F). Fluores-
cent protein expression and siRNA knockdown were tested respec-
tively by flow cytometry (24 h) and Western blot analysis (48 h).
The syntenin-1 GFP fusion proteins Psrα-HAGFP-syntenin-1 and 
syntenin-1-Y1-GFP have been described previously (Sala-Valdes 
et al., 2012). PIP2-enriched plasma membranes were monitored 
during Env-mediated membrane fusion or VLP attachment by 
transfecting cells with the biosensor PLCδ-PH-GFP (Varnai and 
Balla, 1998). GST-syntenin-1-HA and GST-syntenin-1-Myc were 
kindly donated by F. Lozano (Hospital Clinic, Barcelona, Spain).
Negative control siRNA was from Eurogentec (Serain, Belgium) 
and the specific siRNAs against syntenin-1 were from Thermo Scien-
tific Dharmacon (oligonucleotides J-008270-08 and J-008270-06).
Preparation and production of HIV-1 and virus attachment 
and entry assay
Preparation of HIV-1 NL4.3 and measurement of viral replication 
were as previously described (Valenzuela-Fernandez et al., 2005). 
Gag-GFP and Gag-Cherry fluorescent VLPs were produced as previ-
ously described (Izquierdo-Useros et al., 2009) by cotransfecting 
293T cells with the HIV Gag-eGFP/Cherry plasmids and the enve-
lope plasmid pHXB2.
regard, in a preliminary attempt to assess syntenin-1 partners, we 
have observed its association with ERMs and PI4P5K-I (Gordon-
Alonso et al., unpublished data). One possibility is that syntenin-1 
may be able to prevent ERMs from fulfilling their role of in facilitat-
ing HIV-1 entry but without affecting CD4/CXCR4 clustering. A 
second option is that syntenin-1 is limiting PI4P5K-I PIP2 produc-
tion, and therefore, inhibiting HIV-1 entry (Barrero-Villar et al., 
2008). The complexity of syntenin-1 relationships deserves further 
investigation. Alternatively, depletion of syntenin-1 might simply 
allow a higher pool of free PIP2 to accumulate at the plasma mem-
brane after HIV-1 attachment, where it could mediate the recruit-
ment of proteins, such as, ERMs, that facilitate HIV entry (Barrero-
Villar et al., 2008, 2009).
The fact that syntenin-1 clustering around the virus-like particle 
vanishes after viral entry is consistent with participation of syntenin-1 
at the plasma membrane during HIV-1 entry, probably as a conse-
quence of its association with CD4 or its recruitment through PIP2. 
We therefore propose a dynamic model in which syntenin-1 is first 
recruited to the viral attachment site through CD4 and/or PIP2. At 
this location, syntenin-1 would trigger F-actin polymerization via Rac 
GTPase, as has also been suggested for other processes mediated 
by this GTPase (Sala-Valdes et al., 2012). This is consistent with the 
fact that Rac is the Rho GTPase specifically activated during HIV-1 
entry (Pontow et al., 2004; Harmon et al., 2010). Because syntenin-1 
regulates Rac-triggered F-actin polymerization through the adaptor 
protein M-Rip during T chemotaxis (Sala-Valdes et al., 2012), it is 
conceivable that this or a similar signaling axis could be involved 
during HIV-1 entry. Indeed, syntenin-1 Tyr-4 is essential for Rac-me-
diated T-cell chemotaxis and superantigen presentation (Sala-Valdes 
et al., 2012) and seems also to be crucial for syntenin-mediated in-
hibition of HIV infection. Subsequently, F-actin must be locally de-
polymerized to facilitate the nucleocapsid entry (Yoder et al., 2008; 
Vasiliver-Shamis et al., 2009), which is favored (F-actin depolymeriza-
tion) in the absence of syntenin-1. In this context, PIP2 induction by 
HIV-1 might be the signal that shuts down local F-actin polymeriza-
tion while activating F-actin clearance.
In summary, our results have unveiled a critical regulatory role for 
syntenin-1 in controlling HIV-1 entry into target T-cells through alter-
ing actin polymerization, most likely in a PIP2-regulated manner.
MATERIALS AND METHODS
Cell lines and reagents
The Jurkat-derived human T-cell line J77 Vβ8+ J77cl20 was grown in 
RPMI 1640 medium supplemented with 10% fetal bovine serum 
(FBS; Cambrex Bioscience, Charles City, IA). The CEM-T4 human 
T-lymphoblast–like cell line (courtesy of Paul Clapman), and the 
HxBc2 Jurkat-derived T-cell line (courtesy of Joseph Sodrowski) 
were obtained from the National Institutes of Health (NIH) AIDS 
contacts between infected MT4-HIV-GFP cells and silenced or control target cells was quantified using the synapse-
measure plug-in of Image J. The medians and interquartile ranges are shown. More than 100 conjugates were counted 
for each condition in two independent experiments (p = 4.08 × 10−31). (D) MT4-HIV-GFP infected T-cells were incubated 
with control or syntenin-depleted target T-cells for 2 h, fixed, and stained for PIP2 with anti-PIP2 mAb. Quantified PIP2 
labeling at Env-mediated cell contacts is presented as the percentage of PIP2 accumulated at cell contacts. More than 
100 conjugates were counted for each condition (p = 1.1 × 10−5). (E) Env+ HxBc2 T-cells were incubated with control or 
syntenin-depleted target T-cells for 2 h and then fixed, and the conjugates were stained for PIP2 with anti-PIP2 mAb. 
Quantified PIP2 labeling at cell contacts is presented as the percentage of PIP2 accumulated at heterotypic Env-driven 
cell–cell contacts and at homotypic Env-independent contacts (between two target T-cells). More than 100 conjugates 
were counted for each condition (p = 2.1 × 10−4). (F) Control or syntenin-depleted cells expressing PLCδ-PH-GFP were 
incubated with fluorescent VLPs (Gag-Cherry) for 30 min, fixed, and analyzed by confocal microscopy. The bar chart 
shows quantification of PIP2 enrichment at VLP contacts, presented as the percentage of PIP2 recruited to VLP–cell 
contacts. More than 100 VLP contacts were counted for each condition (p = 0.038). The right panel shows a sample 
confocal image in which several VLPs are attached to one pole of the target T-cell (arrows). Scale bar: 5 μm.
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ples were permeabilized for 5 min with 0.5% Triton X-100 in TBS, 
stained and mounted in Prolong (Invitrogen, Camarillo, CA). Images 
were obtained with a photomicroscope (DMR; Leica, Germany) fit-
ted with an HCX PL APO 63×/1.32-210.6 oil-immersion objective 
(Leica; Germany) and coupled to a COHU 4912–5010 charge-cou-
pled camera.
Confocal images were obtained with a Leica TCS-SP5 confocal 
scanning laser microscope fitted with either an HCX PL APO lambda 
blue 63×/1.4 or an HCX PL APO lambda blue 100×/1.4 oil-immer-
sion objective and analyzed with Image J. For clustering quantifica-
tion, staining intensities were transformed with the pseudocolor-in-
tensity look-up-table (LUT). Yellow-white patches at VLP locations 
were considered positive for clustering. For analyzing F-actin accu-
mulation at cell–cell contacts, Image J software was used as previ-
ously described (Calabia-Linares et al., 2011).
Western blotting
J77 T-cells were lysed in 1% NP-40 in TBS supplemented with a 
cocktail of protease inhibitors and phosphatase inhibitors. Lysates 
were centrifuged at 11,000 rpm for 10 min at 4°C, and supernatants 
were mixed with reducing Laemmli buffer and boiled for 5 min. 
Lysates were separated by SDS–PAGE and immunoblotted with 
specific antibodies. Protein bands were analyzed using the LAS-
1000 CCD system and Image Gauge 3.4 software (Fuji Photo Film, 
Tokyo, Japan).
Flow cytometry
Cells were incubated with TBS 5% BSA for 30 min at 4°C and then 
with primary monoclonal antibody (30 min at 4°C). After being 
washed, cells were incubated with a fluorescein isothiocyanate 
(FITC)-conjugated secondary antibody and analyzed in a FACScali-
bur flow cytometer (Becton Dickinson, Franklin Lakes, NJ). Data were 
analyzed with Cell-Quest Pro (Becton Dickinson).
F-actin quantification
Cells were stimulated with HIV NL4.3 free virions (100 ng/million 
cells), fixed with 4% formaldehyde at different time points, permea-
bilized with TBS 0.5% Triton X-100 (5 min), and stained with Phalloi-
din-Alexa647 (Molecular Probes, Camarillo, CA). Mean fluorescence 
intensity of F-actin staining was analyzed on a FACScalibur cytometer 
(BD Biosciences, Franklin Lakes, NJ).
Statistical analysis
Statistical significance was calculated using Student’s t test or the 
parametric one-way analysis of variance with Bonferroni’s post hoc 
multiple-comparison test. Significant differences are labeled 
(*, p < 0.05; **, p < 0.01; ***, p < 0.001).
For p24 production, T-cells were infected with 100 ng of HIV-1 
NL4.3 per million cells for 2 h at 37°C (which is equivalent to 1–2 
multiplicity of infection or viral particles per cell), and then exten-
sively washed with medium to remove nonattached viral particles. 
Infected T-cells were kept in culture for 3 d, at which time superna-
tants were harvested and p24 concentration measured by ELISA 
(Innotest HIV-1 antigen mAb; Innogenetic, Ghent, Belgium).
For HIV attachment and entry measurements, T-cells were in-
fected with 20 ng of HIV-1 NL4.3 per million cells for 2 h at 4°C 
(attachment) or 37°C (attachment + entry), and then extensively 
washed to remove viral input and lysed with RIPA buffer (50 mM Tris 
HCl, pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS). p24 was measured by ELISA (Innotest HIV-1antigen 
mAb; Innogenetic).
Luciferase virus assay
Replication-deficient luciferase-HIV-1 particles were kindly provided 
by Suryaram Gummuluru (Boston University, Boston, MA). Replica-
tion-deficient viral particles were produced by cotransfecting 293T 
cells with the luciferase-expressing reporter virus, HIV/Δnef/Δenv/
luc+, which contains the luciferase gene inserted into the nef 
open reading frame and does not express env glycoprotein 
(Yamashita and Emerman, 2004), and a CXCR4-tropic (Lai) env 
glycoprotein or non–T-tropic VSV glycoprotein. Virus stocks were 
generated by PolyFect transient cotransfection of HEK293T cells 
(Gummuluru et al., 2002). Two days after transfection, cell-free virus-
containing supernatants were clarified of cell debris and concentrated 
by centrifugation (16,000 × g, 1 h at 4°C) and stored at −80°C until 
required. HIV-1 virus preparations were titrated by p24-ELISA. T-cells 
were infected with 200 ng of luciferase-based virus with X4-tropic 
HIV-1 envelope or VSV envelope per million cells for 2 h. Cells were 
washed extensively and luciferase activity was measured at 48 h after 
infection with a luciferase assay kit (Promega Corporation, Madison, 
WI) on a 1450 Microbeta Luminescence Counter (Walax, Trilux).
Env-induced cell fusion assay
A dual-fluorescence cell-fusion assay was performed as described 
previously (Gordon-Alonso et al., 2006). Briefly, CMTMR-loaded 
Env+ Jurkat-Hxbc2 cells were mixed with calcein-AM–loaded paren-
tal or transfected CEM-T4 cells. Fluorescence events were detected 
14 h later by flow cytometry. Fusion was quantified as the ratio of 
double-positive events to single-positive target cells.
Immunoprecipitation
T lymphoblasts and CEM T-cells were lysed in 1% NP-40, 1 mM 
MgCl2, 1 mM CaCl2 in Tris-buffered saline (TBS) supplemented with 
protease and phosphatase inhibitor cocktails. J77 T-cells (4 × 107) 
were lysed in 1% NP-40 in TBS supplemented with a protease in-
hibitor cocktail. Lysates were centrifuged at 11,000 rpm for 10 min 
at 4°C, and cell lysate supernatants were incubated for 2 h at 4°C 
with cyanogen bromide (CNBr) beads (Amersham, Uppsala, Swe-
den) blocked with bovine serum albumin (BSA). Supernatants were 
then incubated with the indicated antibody covalently coupled to 
CNBr beads for 2 h at 4°C. Pellets were washed with lysis buffer, 
resuspended in reducing Laemmli buffer, and processed for West-
ern blotting with the indicated antibodies.
Immunofluorescence and confocal microscopy
T-cells incubated with viral particles, Env+ cells (HxBc2), or HIV-1 in-
fected cells (MT4-HIV-GFP) were seeded on 50 μg/ml poly-l-lysine 
for 30 min and fixed with 3% paraformaldehyde. For staining of in-
tracellular proteins (endogenous syntenin-1, F-actin, and PIP2), sam-
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